Last reviewed · How we verify

NCT06120634

Comparison of Outcomes of Circumcision Via Open and Plastibell Methods

Completed NA Last updated 7 November 2023
What this trial tests

NA trial testing Open surgical method in Circumcision, Male in 608 participants. Completed in 31 October 2020.

Timeline
2 July 2018
Primary endpoint
30 September 2020
31 October 2020

Quick facts

Lead sponsorTehsil Headquarter Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment608
Start date2 July 2018
Primary completion30 September 2020
Estimated completion31 October 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Tehsil Headquarter Hospital

Who can join

Adults 1 Month to 60 Months, male only, with Circumcision, Male. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Circumcision is considered one of the most common elective surgical procedures, particularly among Muslim and Jewish males. Of all the available techniques, Plastibell is gaining traction amongst surgeons due to its safety in the form of a lower complication rate. The current quasi-experimental study aimed to compare the Open and Plastibell methods of circumcision in a study population which comprised of boys up to 5 years of age who were grouped into the Open method and Plastibell based on parental preference. Follow-up occurred on the 5th, 10th, and, 30th post-procedural day. Basic demographic data, procedural duration, and outcomes were documented.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Circumcision, Male

Currently open trials in the same condition.

Other Tehsil Headquarter Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06120634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing